Clinical trials patients are usually faceless. With Modern's Covid-19 vaccine candidate, it has a much more visible advocate: trial volunteer Ian Haydon.
Data from hospital records will be critical to getting a better handle on Covid-19, but making that data usable for researchers is a painstaking process.
With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.
Biopharma breakthroughs, business, and policy analysis — at your fingertips
Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don’t be the last to know. Subscribe today to start reading.
What a month ago had been merely an intriguing lab finding about testing wastewater to detect the coronavirus has leapt to the threshold of real-world use.
Vertex has sparked anger among cystic fibrosis patients by requesting extra time to submit evidence for a new therapy to a U.K. cost-effectiveness agency